We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. CareCloud, Inc. is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
CareCloud, Inc. is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CareCloud, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CCLD's full-year earnings has moved 2.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, CCLD has moved about 7.5% on a year-to-date basis. At the same time, Medical stocks have lost an average of 3.9%. This shows that CareCloud, Inc. is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Caribou Biosciences, Inc. (CRBU - Free Report) . The stock has returned 18.2% year-to-date.
For Caribou Biosciences, Inc., the consensus EPS estimate for the current year has increased 11.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CareCloud, Inc. belongs to the Medical Info Systems industry, which includes 42 individual stocks and currently sits at #81 in the Zacks Industry Rank. On average, stocks in this group have lost 22.3% this year, meaning that CCLD is performing better in terms of year-to-date returns.
On the other hand, Caribou Biosciences, Inc. belongs to the Medical - Biomedical and Genetics industry. This 444-stock industry is currently ranked #143. The industry has moved +2.7% year to date.
Investors interested in the Medical sector may want to keep a close eye on CareCloud, Inc. and Caribou Biosciences, Inc. as they attempt to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. CareCloud, Inc. is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
CareCloud, Inc. is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CareCloud, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CCLD's full-year earnings has moved 2.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, CCLD has moved about 7.5% on a year-to-date basis. At the same time, Medical stocks have lost an average of 3.9%. This shows that CareCloud, Inc. is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Caribou Biosciences, Inc. (CRBU - Free Report) . The stock has returned 18.2% year-to-date.
For Caribou Biosciences, Inc., the consensus EPS estimate for the current year has increased 11.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CareCloud, Inc. belongs to the Medical Info Systems industry, which includes 42 individual stocks and currently sits at #81 in the Zacks Industry Rank. On average, stocks in this group have lost 22.3% this year, meaning that CCLD is performing better in terms of year-to-date returns.
On the other hand, Caribou Biosciences, Inc. belongs to the Medical - Biomedical and Genetics industry. This 444-stock industry is currently ranked #143. The industry has moved +2.7% year to date.
Investors interested in the Medical sector may want to keep a close eye on CareCloud, Inc. and Caribou Biosciences, Inc. as they attempt to continue their solid performance.